Google AI Alphafold 3 could supercharge biological research and drug discovery

Publicly released:
International
Isomorphic Labs
Isomorphic Labs

AlphaFold 3, an AI model for looking at protein and molecular structures, could open up exciting possibilities for drug discovery, agricultural research, biological research, genetics, and more, according to researchers at Google DeepMind and Isomorphic Labs. The program is trained on the Protein Data Bank, and is able to process over 99% of all known biomolecular complexes contained in that database. It produces highly accurate predictions of proteins and their interactions with other biological molecules, which is essential for understanding all kinds of biological processes. The team say researchers can now create and test hypotheses at the atomic level, and produce structure predictions within seconds, rather than the months or years it could take without the technology. Like other AI, the authors note some limitations in the program, including some incorrect chirality (a symmetry property), and hallucinations, but the team says the program’s accuracy significantly exceeds that of current prediction tools.

Media release

From: Springer Nature

Structural biology: AlphaFold 3 widens and improves structure prediction accuracy for protein–molecule interactions *PRESS BRIEFING*

The ability of AlphaFold 3 to produce highly accurate predictions of the structures of proteins interacting with other biological molecules is reported in Nature this week. AlphaFold 3, the latest iteration of the artificial intelligence model created by researchers at Google DeepMind and Isomorphic Labs, demonstrates substantially better accuracy over previous specialist tools. This new model can predict the structures of complexes containing nearly all molecule types within the Protein Data Bank. The ability to computationally determine complex interactions between proteins and other molecules will expand our understanding of biological processes and could facilitate drug development.

First released in 2020, AlphaFold and its later iteration, AlphaFold 2, enabled prediction of the 3D structure of a protein from its sequence of amino acids (the building blocks of proteins). Subsequently, AlphaFold-Multimer facilitated prediction of protein–protein complexes. Broadening the range of complexes whose structure a single deep learning model can predict has been challenging, owing to the vast differences in specific interaction types.

Substantial improvements to the AlphaFold 2 model’s deep learning architecture and training system have now made it possible to more accurately predict the structure of a wide range of biomolecular systems in a unified framework, John Jumper and colleagues report. AlphaFold 3 can predict complexes of proteins with other proteins, nucleic acids, small molecules, ions and modified protein residues, as well as antibody–antigen interactions. Its accuracy significantly exceeds that of current prediction tools, including AlphaFold-Multimer.

The authors note some limitations, such as incorrect chirality (a symmetry property) occurring in around 4.4% of structures, or hallucinations resulting in a reduction in the appearance of ribbons (a common protein secondary structure element). They add that further improvements in modelling accuracy would require the generation of a large set of predictions and ranking of the resulting structures, which would incur an additional computational cost.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page The URL will go live after the embargo lifts.
Journal/
conference:
Nature
Research:Paper
Organisation/s: Google DeepMind, UK
Funder: Funding information not provided; Competing interests: Author-affiliated entities have filed US provisional patent applications including 63/611,674, 63/611,638 and 63/546,444 relating to predicting three-dimensional (3d) structures of molecule complexes using embedding neural networks and generative models. All authors other than A. Bridgland, Y.A.K. and E.Z. have commercial interests in the work described.
Media Contact/s
Contact details are only visible to registered journalists.